Literature DB >> 27190607

Anemia in a neonate with placental mesenchymal dysplasia.

Satoshi Ishikawa1, Mamoru Morikawa1, Takeshi Umazume1, Takahiro Yamada1, Hiromi Kanno2, Emi Takakuwa2, Hisanori Minakami1.   

Abstract

Causes of intrauterine fetal death (IUFD) are uncertain in most placental mesenchymal dysplasia (PMD) cases. Our case showed high α-fetoprotein levels in the maternal circulation, markedly dilated subchorionic vessels, and neonatal hemoglobin concentration of 8.4 g/dL, suggesting that fetal anemia may explain some adverse outcomes in PMD pregnancies.

Entities:  

Keywords:  Alpha fetoprotein elevation; fetal death; placental mesenchymal; placental pathology; placental transfer

Year:  2016        PMID: 27190607      PMCID: PMC4856236          DOI: 10.1002/ccr3.543

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN: 2050-0904


Introduction

Although placental mesenchymal dysplasia (PMD) can coexist with a completely normal fetus, a review of 82 cases indicated that approximately 40% of fetuses with PMD die in utero 1. However, the cause of intrauterine fetal death (IUFD) is uncertain in most PMD cases. Abrupt worsening of fetal condition was documented within 1 day after confirming fetal well‐being in at least two PMD cases 2, 3. These reports prompted us to recommend early admission of a woman with PMD at gestational week (GW) 30 to our hospital for intensive monitoring of fetal well‐being. This case suggested that the intensive monitoring of fetal well‐being using ultrasound contributes to the avoidance of IUFD in some PMD cases. The Hokkaido University Hospital Institutional Review Board approved this study and the patient provided written informed consent.

Case History

A 26‐year‐old nulliparous Japanese woman in GW 13 was referred to our hospital for suspected partial hydatidiform mole. Blood flow in the mole‐like placental cysts on color Doppler ultrasound study suggested PMD 4 in this patient. The fetal middle cerebral artery peak systolic velocity (MCA‐PSV) was 23.6 cm/sec (0.59 multiple of the median [MoM]) (Fig. 1), and multiple subchorionic vesicles ~2.0 cm in diameter (Fig. 2A) and unremarkable fetal heart rate trace were seen on the day of prophylactic admission at GW 30‐0/7. The normal serum α‐fetoprotein (AFP) level of 160 ng/mL (corresponding to 1.0 MoM) at GW 23 increased markedly to 7261 ng/mL (22 MoM) on the next day of admission (Fig. 1). The MCA‐PSV increased to 56.9 cm/sec (1.42 MoM), while the vesicle diameter remained 2.3 cm 3 days later at GW 30‐3/7. However, the vesicle size increased markedly to 3.3 cm in diameter and an emergent cesarean section was performed at GW 30‐5/7. A premature but otherwise healthy female infant weighing 1550 g was born with 1‐ and 5‐min Apgar scores of 6 and 8, respectively.
Figure 1

Changes in maternal serum α‐fetoprotein (AFP) and fetal middle cerebral artery peak systolic velocity (MCA‐PSV). MoM, multiple of the median.

Figure 2

Ultrasound study of the surface of the placenta (A) and photomicrographs of the dilated but unruptured vessel (B). UC, umbilical cord; *, cirsoid chorionic vessels.

Changes in maternal serum α‐fetoprotein (AFP) and fetal middle cerebral artery peak systolic velocity (MCA‐PSV). MoM, multiple of the median. Ultrasound study of the surface of the placenta (A) and photomicrographs of the dilated but unruptured vessel (B). UC, umbilical cord; *, cirsoid chorionic vessels.

Investigations

The hemoglobin concentrations were 8.3 g/dL and 8.4 g/dL in the cord and neonatal blood, respectively. Histological examination of the placenta weighing 575 g revealed that the vesicle was dilated but vessels were unruptured (Fig. 2B). A further increase in maternal serum AFP level to 10,786 ng/mL (33 MoM) was observed on the day of delivery (Fig. 1), but a normal hemoglobin F level (0.5%) as well as a decreased AFP level (to 4990 ng/mL) was confirmed on postpartum day 3 in this patient.

Outcome and Follow‐Up

The neonate with transient tachypnea of the newborn did not require tracheal intubation, and left hospital at age 104 days after exhibiting normal findings on brain magnetic resonance imaging (MRI) at the age of 93 days.

Discussion

Sudden IUFD was a concern in this patient based on our previous experience 5 and a previous review by Pham et al. 1. An acute increase in diameter of the vesicle in 2 days from 2.3 cm to 3.3 cm in our case prompted us to perform cesarean section at GW 30 with concerns regarding imminent vessel rupture. Although the vessel was not ruptured histologically in the present case, the neonate indeed had anemia. In addition, the present case had very high AFP levels of 22 MoM and 33 MoM on admission and the day of delivery, respectively. Even in the absence of PMD, approximately 10% of fetuses carried by women with a persisting elevated AFP level ≥2.5 MoM die in utero 6. In our previous PMD case with AFP of 2.7 MoM 5, subchorionic vessels dilated to 2.5 cm in diameter were seen on ultrasound performed 1 week prior to IUFD occurring at GW 36 when the patient visited our hospital on an outpatient‐basis due to decreased fetal movement. This case of IUFD was considered to be due to hypovolemia caused by the rupture of cirsoid chorionic vessels 5. A similar case of IUFD at GW 28 was documented with a dilated chorionic vessel 3.5 cm in diameter 7. Among 11 new cases reported by Pham et al. 1 , one was documented to have severe anemia at birth. Placental mesenchymal dysplasia is characterized by stem villous cystic dilation and vesicle formation, placentomegaly, and vascular abnormalities 8. Large dilated (to varying degrees) and tortuous vessels seen on the chorionic plate of PMD placentas have endothelial damage showing hemorrhage into the vessel wall and fibroblastic organization 1, 9, 10. Increased serum level of AFP was seen in the present case and in women with PMD 5, 11 even in the presence of normal AFP level in the amniotic fluid 11. This implied that AFP moved extraordinarily from the fetal circulation to the maternal circulation and may suggest an increased permeability of placental vessels derived from vascular abnormalities, allowing AFP to enter the maternal circulation. In addition, the large dilated and tortuous vessels with placentomegaly may cause increase in vascular bed. If fetal erythropoiesis was insufficient for the increase of vascular bed, especially after an acute increase in vascular bed, fetal anemia would occur even in the absence of vessel rupture. These scenarios may explain fetal anemia and elevated AFP levels in the maternal circulation in this case and adverse outcomes, such as fetal growth restriction, hydrops fetalis, and IUFD in some of PMD pregnancies. Intensive monitoring of the placenta and MCA‐PSV using ultrasound may be helpful to avoid IUFD in some PMD pregnancies.

Conflict of Interest

None declared.
  12 in total

1.  Placental mesenchymal dysplasia and an estimation of the population incidence.

Authors:  Xing Zeng; Moy Fong Chen; Yves-André Bureau; Richard Brown
Journal:  Acta Obstet Gynecol Scand       Date:  2012-05-01       Impact factor: 3.636

Review 2.  Placental mesenchymal dysplasia is associated with high rates of intrauterine growth restriction and fetal demise: A report of 11 new cases and a review of the literature.

Authors:  Truc Pham; Julie Steele; Carla Stayboldt; Linda Chan; Kurt Benirschke
Journal:  Am J Clin Pathol       Date:  2006-07       Impact factor: 2.493

Review 3.  Placental mesenchymal dysplasia.

Authors:  Zahida Parveen; Jane Elaine Tongson-Ignacio; Cory R Fraser; Jeffery L Killeen; Karen S Thompson
Journal:  Arch Pathol Lab Med       Date:  2007-01       Impact factor: 5.534

4.  Placental mesenchymal dysplasia: a report of two cases with review of literature.

Authors:  Sainulabdeen Sheeja; Poothiode Usha; Mohan P Shiny; Thambi Renu
Journal:  Indian J Pathol Microbiol       Date:  2013 Jan-Mar       Impact factor: 0.740

5.  'Stained-glass' sign for placental mesenchymal dysplasia.

Authors:  T Kuwata; H Takahashi; S Matsubara
Journal:  Ultrasound Obstet Gynecol       Date:  2014-03       Impact factor: 7.299

6.  Placental mesenchymal dysplasia associated with transient neonatal diabetes mellitus and paternal UPD6.

Authors:  R Aviram; D Kidron; S Silverstein; I Lerer; D Abeliovich; R Tepper; Z Dolfin; O Markovitch; S Arnon
Journal:  Placenta       Date:  2008-05-16       Impact factor: 3.481

Review 7.  Placental mesenchymal dysplasia.

Authors:  Nogba Pawoo; Debra S Heller
Journal:  Arch Pathol Lab Med       Date:  2014-09       Impact factor: 5.534

8.  Clinical difficulties and forensic diagnosis: histopathological pitfalls of villus mesenchymal dysplasia in the third trimester causing foetal death.

Authors:  Francesco Ventura; Mariangela Rutigliani; Carlo Bellini; Alessandro Bonsignore; Ezio Fulcheri
Journal:  Forensic Sci Int       Date:  2013-05-01       Impact factor: 2.395

9.  Management strategy in pregnancies with elevated second-trimester maternal serum alpha-fetoprotein based on a second assay.

Authors:  Emmanuel Spaggiari; Marie Ruas; Sophie Dreux; Anne-Sylvie Valat; Isabelle Czerkiewicz; Fabien Guimiot; Thomas Schmitz; Anne-Lise Delezoide; Françoise Muller
Journal:  Am J Obstet Gynecol       Date:  2013-01-10       Impact factor: 8.661

10.  Anemia in a neonate with placental mesenchymal dysplasia.

Authors:  Satoshi Ishikawa; Mamoru Morikawa; Takeshi Umazume; Takahiro Yamada; Hiromi Kanno; Emi Takakuwa; Hisanori Minakami
Journal:  Clin Case Rep       Date:  2016-03-22
View more
  2 in total

Review 1.  A Challenging Diagnosis: Placental Mesenchymal Dysplasia-Literature Review and Case Report.

Authors:  Claudia Mehedintu; Francesca Frincu; Oana-Maria Ionescu; Monica Mihaela Cirstoiu; Maria Sajin; Maria Olinca; Elvira Bratila; Aida Petca; Andreea Carp-Veliscu
Journal:  Diagnostics (Basel)       Date:  2022-01-24

2.  Anemia in a neonate with placental mesenchymal dysplasia.

Authors:  Satoshi Ishikawa; Mamoru Morikawa; Takeshi Umazume; Takahiro Yamada; Hiromi Kanno; Emi Takakuwa; Hisanori Minakami
Journal:  Clin Case Rep       Date:  2016-03-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.